Cleared Traditional

K955470 - ACTION POTENTIAL SIMULATION THERAPY DEVICE

K955470 is an FDA 510(k) clearance for ACTION POTENTIAL SIMULATION THERAPY DEVICE, manufactured by Neurotech, Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 327-day FDA review.

K955470 · Neurotech, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1996
Decision
327d
Days
Class 2
Risk

K955470 is an FDA 510(k) clearance for the ACTION POTENTIAL SIMULATION THERAPY DEVICE. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Neurotech, Inc. (Tyler, US). The FDA issued a Cleared decision on October 22, 1996 after a review of 327 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Neurotech, Inc. devices

FDA 510(k) Submission Details - K955470

510(k) Number K955470 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 30, 1995
Decision Date October 22, 1996
Days to Decision 327 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
179d slower than avg
Panel avg: 148d · This submission: 327d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 281
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K955470.
SHE-LI TENS STIMULATOR MODEL SL-101 RX
K961809 · Medi Consultants, Inc. · Feb 1997
SD-610M(ALSO KNOWN AS STANDARD TENS, SD-609M,SD-611M, GLC-I STANDARD)
K963729 · Skylark Device Co., Ltd. · Feb 1997
M AND R REUSABLE ELECTRODES (MULTIPLE)
K963125 · M & R Mfg., Inc. · Feb 1997
SMART-TENS, MODEL 456
K961376 · Bio-Medical Research, Ltd. · Sep 1996
SPEC T.E.N.S. PREWIRED REPOSITIONABLE TENS ELECTRODE - MODIFY
K962910 · Uni-Patch, Inc. · Sep 1996
TENS/FES/NMES ELECTRODES
K962332 · Uni-Patch, Inc. · Jul 1996